Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve and take on record the Unaudited Standalone and Consolidated Financial Results (along with Limited Review Report) for the quarter ended September 30, 2026

Ref: 44/SE/LC/2026-27 Date: October 22, 2026 Scrip Code BSE: 544122 NSE: ENTERO ISIN: INE010601016 Head, Listing Compliance Department Head, Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1 G Block, Mumbai - 400001 Bandra -Kurla Complex, Bandra (East), Mumbai- 400051 Dear Sir/Madam, Sub: Intimation of Notice of Board Meeting Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, November 04, 2026, inter-alia, to consider, approve and take on record the Unaudited Standalone and Consolidated Financial Results (along with Limited Review Report) for the quarter ended September 30, 2026. As informed vide our letter dated September 23, 2026, the trading window for dealing in the securities of the Company is closed for all designated persons and their immediate relatives with effect from October 01, 2026, and will continue to remain closed till completion of 48 hours after declaration of aforesaid results unless communicated otherwise. This is for your information and records. Yours Faithfully For Entero Healthcare Solutions Limited Sanu Kapoor Vice President- Group General Counsel, Company Secretary & Compliance Officer